electroCore, Inc. has recently announced an exclusive distribution agreement with Reliefband Technologies, LLC. This agreement allows electroCore to distribute Reliefband's ReletexTM device within the Department of Veterans Affairs and other eligible entities. The Reletex device is a non-invasive neuromodulation device that has been cleared by the FDA for the treatment of nausea and vomiting. As part of this agreement, electroCore will be responsible for distributing and billing the device.
Reliefband Technologies is well-known for their innovative wearable technology that effectively treats nausea and vomiting. Through their partnership with electroCore, they are now able to provide their prescription non-drug solution to veterans through VA hospitals and other eligible entities. Both companies are excited about this collaboration as it will give veterans access to a highly effective treatment option.
Dan Goldberger, CEO of electroCore, expressed his enthusiasm for offering the Reletex product to their customer base. He believes that the drug-free and patient-controlled nature of Reletex makes it an ideal solution for veterans who suffer from nausea and vomiting.